FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma

@article{Shi2018FGFR2RB,
  title={FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma},
  author={Yuanyuan Shi and Xuejiao Liu and Mangaladoss Fredimoses and Mengqiu Song and Hanyong Chen and Kangdong Liu and Mee‐Hyun Lee and Zigang Dong},
  journal={Journal of Cellular Biochemistry},
  year={2018},
  volume={119},
  pages={2231 - 2239}
}
Fibroblast growth factor receptor (FGFR) 2 and its downstream signaling cascades, PI3 K/AKT/mTOR is playing an important role in cell survival and proliferations. In this study, we firstly found that picrasidine Q (PQ), an alkaloid component extracted from Angelica keiskei species, has the capacity of anti‐cell transformation and anti‐cancer. After ligand shape similarity approach of PQ, we found that PQ targeted FGFR 2 and verified by FGFR2 kinase assay as well as computational docking model… 
Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
TLDR
HF has been identified as a cisplatin sensitizer and a dual pathway inhibitor, which might provide a new strategy to improve prognosis of patients with cisPlatin-resistant lung cancer.
Anticancer effects of picrasidine I on oral squamous cell carcinoma
TLDR
Analysis of MAPK signaling pathway revealed that picrasidine I‐mediated proapoptotic activities by downregulating JNK phosphorylation is identified as a potent anticancer agent that can be used as a therapeutic intervention against oral squamous cell carcinoma.
FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma
TLDR
It is shown that each FGFR has a distinct role and FGFR2-AKT signaling is a key driver of keratinocyte differentiation in ESCC.
Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo
TLDR
It is found that xanthohumol acts as a KRT18 regulator to suppress the growth of ESCC and reduces tumor volume and weight in patient-derived xenografts (PDXs) tumors having overexpressed K RT18.
Blocking FGFR4 exerts distinct anti‐tumorigenic effects in esophageal squamous cell carcinoma
TLDR
The FGFR family can be activated by FGFs and plays important roles in regulating cell growth, differentiation, migration, and angiogenesis, and the potential roles of FGFR4 in ESCC remain unknown.
Inhibition of esophageal cancer cell line (KYSE-30) proliferation using secondary metabolites of Ephedra endophyte bacteria
TLDR
The potentials of Ephedra endophyte bacteria for the inhibition of esophageal cancer cell line (KYSE-30) proliferation were investigated and MTT assay results showed that only strain A1 had a cytotoxic effect on KYSE- 30 cells.
Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents
TLDR
This work established and validated organoids derived from tissues dissected from a patient with metastatic tRCC with PRCC-TFE3 fusion and achieved the HTS process for the first time.
Effects of Enantiomerically Pure β-Carboline Alkaloids from Picrasma quassioides on Human Hepatoma Cells.
TLDR
Four pairs of β-carboline enantiomers with a single enantiomeric configuration, together with 2 known achiral congeners, were isolated from the stems of Picrasma quassioides and screened for their cytotoxicity against hepatocellular carcinoma Hep3B and HepG2 cells, which revealed that enantomeric compounds 4A: and 4B: had distinctive effects in HepG 2 cells.
Bioassay-Guided Interpretation of Antimicrobial Compounds in Kumu, a TCM Preparation From Picrasma quassioides’ Stem via UHPLC-Orbitrap-Ion Trap Mass Spectrometry Combined With Fragmentation and Retention Time Calculation
TLDR
This study clearly showed the antimicrobial chemical basis of Kumu, and the results demonstrated that HRMS coupled with MS Fragmenter and ChromGenius was a powerful tool for compound analysis, which can be used for other complex samples.

References

SHOWING 1-10 OF 41 REFERENCES
FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival.
TLDR
It is revealed that both the FGFR2 and EGFR family signaling pathways are activated inFGFR2-amplified gastric cancer cell lines to drive cell proliferation and survival.
FGFR2 Is Amplified in the NCI-H716 Colorectal Cancer Cell Line and Is Required for Growth and Survival
TLDR
The first characterization of FGFR2 gene amplification in colorectal cancer in the NCI-H716 cell line is reported, suggesting that emerging FGFR inhibitor therapeutics may have efficacy in a subset of colon cancer driven byFGFR2 amplification.
Antitumor Effects and Mechanisms of AZD4547 on FGFR2-Deregulated Endometrial Cancer Cells
TLDR
This study found that AZD4547 exhibits its therapeutic activity against endometrial cancer cells by perturbing various regulatory mechanisms related to FGFR signaling, including EGR1, ELK-1/SRF, AP-1, and NFκB.
Fibroblast Growth Factor Receptor 2–Positive Fibroblasts Provide a Suitable Microenvironment for Tumor Development and Progression in Esophageal Carcinoma
TLDR
It is hypothesized that FGFR2(+)-TFs might provide cancer cells with a suitable microenvironment via secretion of proteins that could promote cancer development and progression through stimulation of cancer cell proliferation, induction of angiogenesis, inhibition of cell adhesion, enhancement of cell mobility, and promotion of the epithelial-mesenchymal transition.
In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine
TLDR
Isopraeroside IV and aurantiamide acetate are proposed as potential lead compounds for further study in drug development process with the PARP-1 protein.
Fibroblast and Epidermal Growth Factors Utilize Different Signaling Pathways to Induce Anchorage-independent Cell Transformation in JB6 Cl41 Mouse Skin Epidermal Cells
TLDR
FGF acts as a tumor promoter and dual inhibition of kaempferol on the kinase activities of FGFR3 and RSK2 suppresses the FGF-induced neoplastic cell transformation through a non-canonical signaling pathway which is not utilized by EGF stimulation.
Immortal phenotype of the esophageal epithelial cells in the process of immortalization.
TLDR
The relative level of telomerase activity and other immortal phenotypes in the SHEE esophageal epithelial cell line is investigated to search for potential biomarkers used to monitor the process of immortalization.
Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
TLDR
The frequent gene amplification of EGFR, HER2 and FGFR2 and the presence of active EGFR mutations were observed in ESCC specimens and strongly encourage the development of molecular targeted therapy for ESCC.
The Fibroblast Growth Factor signaling pathway
  • D. Ornitz, N. Itoh
  • Biology
    Wiley interdisciplinary reviews. Developmental biology
  • 2015
TLDR
Members of the FGF family function in the earliest stages of embryonic development and during organogenesis to maintain progenitor cells and mediate their growth, differentiation, survival, and patterning.
...
1
2
3
4
5
...